If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...
The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
Biden administration's proposal to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...
The White House said Tuesday it is moving to make Medicare and Medicaid cover anti-obesity drugs such as Novo Nordisk’s ...
The Biden administration on Tuesday proposed expanding drug coverage under Medicare and Medicaid to include anti-obesity ...
Under the proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The Biden administration is reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity ...